Development of Vaccines Against Influenza A (H5N1) Virus Should be Made a Priority, Experts Say
Newswise -- Two studies in this week's issue of The Lancet raise questions about the transmission of avian influenza viruses from chickens to humans. Marion Koopmans of the National Institute of Public Health and the Environment, The Netherlands, and colleagues describe a large outbreak of avian influenza A/H7 in commercial poultry farms in the Netherlands in 2003. They note that the size of the outbreak, coinciding with peak activity of human influenza virus, reinforces the message that emergence of new pandemic influenza viruses might arise via the mixing of genes from avian and human viruses.
Koopmans comments, "We noted an unexpectedly high number of transmissions of avian influenza A virus subtype H7N7 to people directly involved in handling infected poultry, and we noted evidence for person-to-person transmission. Our data emphasise the importance of adequate surveillance, outbreak preparedness, and pandemic planning." In a research letter, Malik Peiris and colleagues at the University of Hong Kong suggest that some avian influenza viruses pose a substantial threat to human health, and after the re-emergence of H5N1 disease in humans, the authors draw our attention to the need to develop a vaccine against the virus.
In a commentary, Maria Zambon, with the Health Protection Agency in the United Kingdom, states that influenza A transmission from animals to humans remains a rare event, but one which history teaches us we must take seriously to avoid a further pandemic of influenza like that of 1918.
Source: The Lancet
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
